Health

#13: Hope for HIV Vaccine

In the unforgiving world of AIDS vaccines, even a modestly protective effect is big news.

By Nayanah SivaJan 25, 2010 12:00 AM

Newsletter

Sign up for our email newsletter for the latest science news
 

An international team of researchers announced in September that for the first time, an AIDS vaccine has demonstrated some real ability to prevent HIV infections in a large clinical trial, reducing the odds of infection by about 31 percent.

The trial followed more than 16,000 people (who initially tested HIV-free) for three and a half years. They received either a combination of two potential vaccines or placebo shots. By the end, 74 placebo recipients had acquired HIV infections, compared with 51 vaccinated individuals. The trial report, published in October, included alternative analyses that put the vaccine’s effectiveness slightly lower, at around 26 percent, leading some to question the reliability of the results. The researchers reply that all of the analyses consistently support a modest protective effect.

AIDS researcher Jay Levy at the University of California at San Francisco finds the results encouraging, but notes that the vaccines seemed to have no effect on the amount of virus in the bloodstream of people who contracted HIV during the study. Nelson Michael of the U.S. Military HIV Research Program, which helped run the trial, is more optimistic: “We’ve shown that this 26-year global effort has not been in vain.”

1 free article left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

1 free articleSubscribe
Magazine Examples
Want more?

Keep reading for as low as $1.99!

Subscribe

Already a subscriber?

Register or Log In

More From Discover
Recommendations From Our Store
Shop Now
Stay Curious
Join
Our List

Sign up for our weekly science updates.

 
Subscribe
To The Magazine

Save up to 70% off the cover price when you subscribe to Discover magazine.

Copyright © 2021 Kalmbach Media Co.